Foot and Mouth Disease: a Revised Policy Is Required

per Bayry, Jagadeesh, Kaveri, Srini V.
Publicat 2001

Foreword

per Jolles, S, Kaveri, S V, Orange, J
Publicat 2009

Current understanding and future directions

per Jolles, S, Kaveri, S V, Orange, J
Publicat 2009

Human anti-phosphorylcholine antibodies share idiotopes and are self-binding.

per Halpern, R, Kaveri, S V, Köhler, H
Publicat 1991

Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

per Kaveri, S V, Mouthon, L, Kazatchkine, M D
Publicat 1994

Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.

per Ronda, N, Kaveri, S V, Kazatchkine, M D
Publicat 1993

Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease

per Bayry, Jagadeesh, Mouthon, Luc, Kaveri, Srini V.
Publicat 2012

Th17 cells, pathogenic or not? TGF-β3 imposes the embargo

per Sharma, Meenu, Kaveri, Srini V, Bayry, Jagadeesh
Publicat 2013

Intravenous immunoglobulin as clinical immune-modulating therapy

per Gilardin, Laurent, Bayry, Jagadeesh, Kaveri, Srini V.
Publicat a CMAJ (2015)

Cross-presentation of antigens by dendritic cells: role of autophagy

per Das, Mrinmoy, Kaveri, Srini V., Bayry, Jagadeesh
Publicat a Oncotarget (2015)

The Homophilic Domain – An Immunological Archetype

per Kohler, Heinz, Bayry, Jagadeesh, Kaveri, Srinivas V.
Publicat a Front Immunol (2016)

Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli

per Maddur, Mohan S., Kaveri, Srini V., Bayry, Jagadeesh
Publicat a Cell Mol Immunol (2018)

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)

per Galeotti, Caroline, Kaveri, Srini V, Bayry, Jagadeesh
Publicat a Clin Transl Immunology (2020)

Natural IgM in immune equilibrium and harnessing their therapeutic potential

per Kaveri, Srini V., Silverman, Gregg J., Bayry, Jagadeesh
Publicat 2012

Impaired regulatory T cell function in autoimmune diseases: are microRNAs the culprits?

per Sharma, Varun K, Kaveri, Srini V, Bayry, Jagadeesh
Publicat a Cell Mol Immunol (2016)

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.

per Kaveri, S V, Dietrich, G, Hurez, V, Kazatchkine, M D
Publicat 1991

Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis

per Othy, Shivashankar, Topçu, Selma, Kaveri, Srini V., Bayry, Jagadeesh
Publicat 2012

DC-SIGN and α2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

per Bayry, Jagadeesh, Bansal, Kushagra, Kazatchkine, Michel D., Kaveri, Srini V.
Publicat 2009

Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy

per Kaveri, S V, Maddur, M S, Hegde, P, Lacroix-Desmazes, S, Bayry, J
Publicat 2011

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin

per Galeotti, Caroline, Bayry, Jagedeesh, Kone-Paut, Isabelle, Kaveri, Srinivas V.
Publicat a Autoimmun Rev (2010)